Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Revenue (2016 - 2025)

Apyx Medical's Revenue history spans 15 years, with the latest figure at $19.2 million for Q4 2025.

  • For Q4 2025, Revenue rose 34.75% year-over-year to $19.2 million; the TTM value through Dec 2025 reached $52.8 million, up 9.86%, while the annual FY2025 figure was $52.8 million, 9.86% up from the prior year.
  • Revenue reached $19.2 million in Q4 2025 per APYX's latest filing, up from $12.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $19.2 million in Q4 2025 to a low of $8.6 million in Q1 2021.
  • Average Revenue over 5 years is $12.3 million, with a median of $12.1 million recorded in 2023.
  • Peak YoY movement for Revenue: soared 161.27% in 2021, then fell 25.04% in 2022.
  • A 5-year view of Revenue shows it stood at $16.8 million in 2021, then fell by 25.04% to $12.6 million in 2022, then grew by 16.26% to $14.7 million in 2023, then dropped by 3.0% to $14.2 million in 2024, then surged by 34.75% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Revenue are $19.2 million (Q4 2025), $12.9 million (Q3 2025), and $11.4 million (Q2 2025).